Nonalcoholic steatohepatitis (NASH), characterized by liver steatosis, inflammation and injury, has emerged as one of major causes for end-stage liver disease like hepatocellular carcinoma. However, what drives its progression?
Aug 25, 2022
0
12
Severe fatty liver disease is commonly associated with obesity, but according to a review of scientific literature conducted by researchers at Temple University and the Translational Genomics Research Institute (TGen), an ...
Mar 24, 2022
0
77
A longitudinal national study led by Virginia Commonwealth University researcher Arun Sanyal, M.D., shows that people with advanced liver scarring caused by obesity, diabetes and related disorders are dying of liver disease.
Oct 21, 2021
0
319
A type of fatty liver disease that commonly affects patients with HIV can be safely treated with vitamin E, a McGill-led study has found.
Feb 14, 2020
0
113
Virginia Commonwealth University researchers have collaborated on a clinical trial that identifies indicators for nonalcoholic fatty liver disease—a typically asymptomatic disease caused by fat buildup in the liver and ...
Nov 21, 2018
0
13
(HealthDay)—Mass spectrometry (MS)-based profiling combined with clinical variables can identify nonalcoholic steatohepatitis (NASH), according to a study published in the October issue of Clinical Gastroenterology and ...
Oct 6, 2016
0
0
Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...
Sep 21, 2016
0
25
(HealthDay)—A novel non-elective inpatient hepatology rotation increases knowledge of chronic liver disease (CLD) among internal medicine (IM) residents, according to a study published online Aug. 10 in Hepatology.
Sep 6, 2016
0
0
(HealthDay)—Weight loss can improve nonalcoholic steatohepatitis (NASH) in obese or overweight people, whether excess pounds are shed through lifestyle changes or weight-loss surgery, according to research published in ...
Aug 24, 2015
0
26
Researchers at the University of Arizona College of Pharmacy have discovered that nonalcoholic steatohepatitis (NASH), an increasingly common but often undiagnosed liver disease, could have significant medical implications ...
Jul 9, 2015
0
12
